Search Patents
-
Publication number: 20130101991Abstract: An apparatus for assaying a tumor drug delivery vehicle and or drug can include an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space) containing animal cells and means for quantifying drug delivery through the IMN to the animal cells.Type: ApplicationFiled: December 14, 2012Publication date: April 25, 2013Applicant: CFD Research CorporationInventor: CFD Research Corporation
-
Publication number: 20130149735Abstract: Methods of assaying the leukocyte adhesion cascade (LAC) and monitoring leukocyte rolling, adhesion, and/or migration can be implemented with an apparatus that includes an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space). The methods of assaying the LAC can be implemented with means for quantifying modulation of the leukocyte adhesion cascade. Methods of assaying the LAC can be implemented with the device and one or more active agents to monitor leukocyte rolling, adhesion, and/or migration in the presence of absence of the active agent. Migration can be through the idealized flow channels, through the porous wall, and/or into the tissue space.Type: ApplicationFiled: January 16, 2013Publication date: June 13, 2013Applicant: CFD RESEARCH CORPORATIONInventor: CFD Research Corporation
-
Publication number: 20100099136Abstract: An apparatus and method for assaying a tumor drug delivery vehicle comprises a synthetic microvascular network of interconnected flow channels in fluid communication through a porous wall with a tissue space containing animal cells and means for quantifying drug delivery from the microvascular network to the animal cells.Type: ApplicationFiled: December 28, 2009Publication date: April 22, 2010Applicant: CFD RESEARCH CORPORATIONInventors: Balabhaskar Prabhakarpandian, Kapil Pant, Shivshankar Sundaram
-
Publication number: 20110104658Abstract: An apparatus and method for assaying blood-brain barrier properties for drug and drug delivery vehicle screening comprising of a microfluidic apparatus with gaps separating lumen and tissue space enabling formation of tight junctions similar to in vivo conditions using endothelial cells and brain cells.Type: ApplicationFiled: March 17, 2010Publication date: May 5, 2011Applicant: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant, Shivshankar Sundaram, Ketan Bhatt
-
Publication number: 20100227312Abstract: A method for characterizing particle adhesion in microfluidic bifurcations and junctions comprises at least one idealized bifurcation or junction. Multiple bifurcations and/or junctions can be combined on a single microfluidic chip to create microfluidic networks configured for assays specifically to characterize particle interactions at junctions or to screen particles for desired interactions with microfluidic bifurcations and/or junctions.Type: ApplicationFiled: March 6, 2009Publication date: September 9, 2010Applicant: CFD RESEARCH CORPORATIONInventors: Kapil Pant, Balabhaskar Prabhakarpandian, Shivshankar Sundaram, Angela Irene Rea-Ramsey
-
Publication number: 20100112550Abstract: An apparatus and method for identifying and screening for agents affecting the leukocyte adhesion cascade (LAC) encompassing rolling, adhesion and migration comprises an optically clear, plastic microfluidic chip comprising flow channels with diameters in the range of 10-500 ?m. The flow channels are coated with endothelial cells and at least a portion of the flow channels contains 1-30 ?m sized openings, optionally filled with a native or synthetic extracellular matrix, that allow leukocyte migration into one or more tissue spaces.Type: ApplicationFiled: November 4, 2009Publication date: May 6, 2010Applicant: CFD RESEARCH CORPORATIONInventor: Shivshankar Sundaram
-
Patent number: 9933413Abstract: A method of assaying metastasis can include: providing a device of one of the embodiments; introducing the at least one cancer cell into the at least one internal chamber or at least one fluid channel; and studying metastasis of the at least one cancer cell. Optionally: introducing cancer cells into a first internal chamber; detecting escape of the cancer cell from the first internal chamber into the fluid channel; detecting migration of the cancer cell through the fluid channel; detecting adhesion of the cancer cell to a coating on the fluid channel; detecting invasion of the cancer cell into a second internal chamber from the fluid channel; or visualizing metastasis of the cancer cell with a visualization device.Type: GrantFiled: March 10, 2014Date of Patent: April 3, 2018Assignee: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant
-
Publication number: 20140255971Abstract: A method of assaying metastasis can include: providing a device of one of the embodiments; introducing the at least one cancer cell into the at least one internal chamber or at least one fluid channel; and studying metastasis of the at least one cancer cell. Optionally: introducing cancer cells into a first internal chamber; detecting escape of the cancer cell from the first internal chamber into the fluid channel; detecting migration of the cancer cell through the fluid channel; detecting adhesion of the cancer cell to a coating on the fluid channel; detecting invasion of the cancer cell into a second internal chamber from the fluid channel; or visualizing metastasis of the cancer cell with a visualization device.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Applicant: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant
-
Patent number: 10641761Abstract: A method of assaying metastasis can include: providing a device of one of the embodiments; introducing the at least one cancer cell into the at least one internal chamber or at least one fluid channel; and studying metastasis of the at least one cancer cell. Optionally: introducing cancer cells into a first internal chamber; detecting escape of the cancer cell from the first internal chamber into the fluid channel; detecting migration of the cancer cell through the fluid channel; detecting adhesion of the cancer cell to a coating on the fluid channel; detecting invasion of the cancer cell into a second internal chamber from the fluid channel; or visualizing metastasis of the cancer cell with a visualization device.Type: GrantFiled: February 15, 2018Date of Patent: May 5, 2020Assignee: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant
-
Publication number: 20140255961Abstract: A method of assaying wound healing can include: growing cells on the matrix in the first flow channel; introducing an agent that removes the matrix from the junction; introducing a matrix material into the second flow channel so as to form the second matrix in the second flow channel and junction; and detecting cellular migration into the junction onto the second matrix. The agent that removes the matrix can include a biomolecule or chemical agent. The method can include removing cells in the matrix in the junction before introducing the matrix material into the second flow channel. A bioactive agent can be introduced into the junction to determine if it modulates cellular migration and/or clot formation into the intersection openings of tissue and vascular channels.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Applicant: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant
-
Publication number: 20140255970Abstract: A cell culture device can include: an internal chamber configured for an internal cell culture that has at least one port coupled to a perfusion modulating device capable of modulating perfusion in the internal chamber; at least one fluid channel bordering the internal chamber that is configured for a channel cell culture that has at least one port coupled to a perfusion modulating device capable of modulating perfusion in the fluid channel; and a wall separating the internal chamber and at least one fluid channel having gaps that fluidly couple the internal chamber with the at least one fluid channel, wherein the perfusion modulating device causes reduced fluid flow. The internal chamber can include a first cell type and the at least one fluid channel includes a second cell type. The first cell type has an ischemic zone in the middle, a non-ischemic zone adjacent with the at least one fluid channel, and a border zone between the ischemic zone and non-ischemic zone.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Applicant: CFD Research CorporationInventors: Balabhaskar Prabhakarpandian, Kapil Pant